Lenvatinib 4 mg , 10 mg Suppliers & Bulk Manufacturers
Available Forms: Oral capsules
Available Strengths: 4 mg , 10 mg
Reference Brands: Lenvima® (EU & US)
Category: Oncology Cancer Care
Lenvatinib (brand name Lenvima®) is an oral tyrosine kinase inhibitor used to treat thyroid cancer, RCC, HCC, and endometrial cancer. Available in 4 mg and 10 mg capsules, it’s approved in the US and EU. Widely sourced by B2B pharma suppliers, Lenvatinib ensures GMP-compliant, reliable supply for oncology centers with competitive pricing.
Product Description: Lenvatinib, marketed as Lenvima® by Eisai, is a potent oral tyrosine kinase inhibitor (TKI) used in oncology to treat thyroid cancer, renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma. Available in 4 mg and 10 mg capsules, Lenvatinib is approved in both the US and EU. It works by inhibiting tumor angiogenesis and cell proliferation. As a high-demand anticancer therapy, it is widely distributed by pharma B2B suppliers across the European and U.S. markets, ensuring GMP-compliant sourcing, consistent availability, and competitive pricing for hospitals, pharmacies, and oncology centers managing advanced cancers.
Lenvatinib — third party manufacturing & bulk supply
Lenvatinib 4 mg , 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lenvatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lenvatinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
